Staying Safe: The Importance of Medication Monitoring as the Pandemic Continues

The COVID-19 pandemic continues to pose significant challenges to the healthcare system, despite widespread availability of vaccines. Variants of the virus…

Cases of Unusual Buprenorphine Concentrations in Urine Drug Tests: What Does This Mean and Clinical Implications?

Buprenorphine is a semisynthetic opioid with partial agonist activity at the mu-opioid receptor, an effective treatment option for opioid use disorder…

NPS Focus: “Nitazene" Synthetic Opioids

Aegis launched an extensive and industry-leading testing menu of Novel Psychoactive Substances (NPS) in mid-2020, which includes phenibut, tianeptine,…

Finding Fentanyl

Synthetic opioids, including fentanyl, buprenorphine, meperidine, methadone and others,1 comprise a class of drugs manufactured in laboratories designed…

Interpretation of Buprenorphine and Naloxone Results: Considerations for Dosage Form and Specimen Type

Buprenorphine prescribing is extremely common across multiple clinical specialties, primarily opioid use disorder (OUD) and pain management treatment providers. …

NPS Focus: Designer Benzodiazepines

 Aegis launched an extensive and industry-leading testing menu of Novel Psychoactive Substances (NPS) in mid-2020, which includes designer benzodiazepines,…

Expansion of Urine Behavioral Health Drug Testing, AcuRiseID™

Aegis Sciences Corporation, a leading healthcare company that provides innovative medication adherence testing, is pleased to announce the expansion of…